BX Swiss TOP 30 CHF
1.290,04
PKT
+5,07
PKT
+0,39
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.05.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.20 | Swiss Re Hold | Deutsche Bank AG | |
| 04.05.20 | UBS Equal-Weight | Morgan Stanley | |
| 04.05.20 | UBS Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.20 | Swiss Re Hold | Deutsche Bank AG | |
| 01.05.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 01.05.20 | Swiss Re buy | UBS AG | |
| 01.05.20 | Holcim Outperform | Credit Suisse Group | |
| 30.04.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 30.04.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 30.04.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 30.04.20 | Holcim buy | Goldman Sachs Group Inc. | |
| 30.04.20 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 30.04.20 | Novartis Hold | HSBC | |
| 30.04.20 | Roche Hold | HSBC | |
| 29.04.20 | UBS Hold | Deutsche Bank AG | |
| 29.04.20 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 29.04.20 | Novartis Neutral | Credit Suisse Group | |
| 29.04.20 | UBS Outperform | Credit Suisse Group | |
| 29.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 29.04.20 | UBS Sector Perform | RBC Capital Markets | |
| 29.04.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 29.04.20 | UBS overweight | JP Morgan Chase & Co. | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Roche buy | UBS AG | |
| 28.04.20 | Novartis Neutral | UBS AG | |
| 28.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 28.04.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 28.04.20 | UBS Sector Perform | RBC Capital Markets | |
| 28.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | UBS overweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | UBS buy | Goldman Sachs Group Inc. | |
| 28.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 28.04.20 | Nestlé Underperform | RBC Capital Markets | |
| 27.04.20 | Roche overweight | Morgan Stanley |